---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-25-000016"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T01:53:47.507137+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# vTv Therapeutics posts updated March 2025 investor presentation; specific content not available for review

## Summary
- Filing is a Reg FD disclosure of a slide deck used for meetings with investors and analysts.
- Deck titled 'Improving the Lives of Millions of People Living with Type 1 Diabetes'.
- No financial results, pipeline data, or material updates can be extracted from the provided excerpt.
- Full presentation content was not included in the filing text; confidence in summarizing news is low.

## SEC filing metadata
- accession: 0001641489-25-000016
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148925000016/0001641489-25-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148925000016/vtvt-20250331.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-25-000016
- JSON: https://secwatch.observer/filing/0001641489-25-000016.json
- Plain text: https://secwatch.observer/filing/0001641489-25-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.